Entries by Nexreg

Feb. 27 – OSHA Issues Final Standard on Hexavalent Chromium

WASHINGTON — The Occupational Safety and Health Administration (OSHA) will publish a final standard for occupational exposure to hexavalent chromium in the Feb. 28, 2006, Federal Register. The standard covers occupational exposure to hexavalent chromium (Cr(VI)) in general industry, construction and shipyards. The standard will be published in accord with the timetable established by the […]

Feb. 22 – Groups seek warning Prop. 65 label for non-stick products

A recent article in the Oroville Mercury Register discusses possible changes to California’s Prop 65: “Non-stick pans, wind-proof coats, even that 40-pound sack of dogfood hauled home from Costco the other day all need a state Proposition 65 warning because they conceal a potential human carcinogen, a coalition of labor and environmental groups said Wednesday. […]

Feb. 22 – FDA Approves First Generic Version of Flonase

The Food and Drug Administration (FDA) today approved Fluticasone Propionate Nasal Spray, the first generic version of the brand name drug Flonase, giving American consumers an additional, lower cost alternative when choosing prescription drug products. “Except for their price, which is much lower, generic drugs are in every way equivalent to their brand name counterparts,” […]

Feb. 22 – The fat of the land (Food labels)

Might there be new food labels regulations coming out of Canada?  The Toronto Star thinks so: Canadians have little in common with the Olympic athletes competing in our name, says Mary Bush, director of the office of nutrition policy and promotion at Health Canada, and a mover in the new food labelling regulations. “The average […]

Feb. 21 – FDA Approves New Treatment for Fungal Infections

The Food and Drug Administration approved Eraxis™ (anidulafungin) to treat certain infections caused by Candida, a yeast-like fungus that can cause serious infections in hospitalized patients or patients with compromised immune systems. “This product offers a new alternative therapy for several types of infections associated with Candida”, said Dr. Steven Galson, director of the FDA’s […]

Feb. 17 – Bristol-Myers Squibb Co. announces labeling changes for Tequin

Today, Bristol-Myers Squibb Co. announced labeling changes for Tequin (gatifloxacin), an antibiotic indicated for the treatment of patients with pneumonia, bronchitis, uncomplicated gonorrhea, and various infections including infections of urinary tract, kidneys, and skin. Information about the risks of low blood sugar and high blood sugar was added to the WARNINGS section of the U.S. […]

Feb. 15 – FDA Provides Guidance on Whole Grain for Manufacturers

The Food and Drug Administration has issued draft guidance on what the term “whole grain” may include. The guidance will assist manufacturers with what the FDA considers appropriate for food label statements related to “whole grain” content. Consumers will now be able to make dietary choices based on a term that is consistent and reliable. […]

Feb. 14 – CPSC Signs MOU with Korea to Improve Consumer Product Safety

The U.S. Consumer Product Safety Commission (CPSC) announced today the signing of a Memorandum of Understanding (MOU) with the Republic of Korea’s government to improve the safety of consumer products exported to the U.S from South Korea. The agreement calls for an exchange of information between the two countries on consumer product safety issues, the […]

Feb. 9 – Chemical company fined $65,000

The U.S. Environmental Protection Agency is seeking a $65,000 penalty from Grow More, Inc., a Gardena, Calif.-based chemical manufacturer, for allegedly selling an antimicrobial disinfectant that was not as effective as the label claimed. This is a violation of federal pesticide law. “Producers of antimicrobial products must ensure that their products kill all the microorganisms […]